07/2013 - Državni zavod za intelektualno vlasništvo

HR - Patenti - Hrvatski glasnik intelektualnog vlasništva 20, 2013, 7, 2169 – 2293 2223Kazalo klasifikacijskih oznaka zahtjevaza proširenje europskih prijavapatenata prema Međunarodnojklasifikaciji patenataMKP Broj objave europske Naziv izumaprijave patenta(51) (97) (54)A61B 18/18 (2006.01) EP 2604214 Auto-aligning ablating deviceA61B 19/00 (2006.01) EP 2604214 Auto-aligning ablating deviceA61K 31/22 (2006.01) EP 2397130 Retinal derivatives and methods for the use thereof for the treatment of visual disordersA61K 31/225 (2006.01) EP 2397130 Retinal derivatives and methods for the use thereof for the treatment of visual disordersA61K 31/343 (2006.01) EP 2385044 Orodispersible tablet and process for preparing the sameA61K 31/404 (2006.01) EP 2610244 Indole compoundsA61K 31/415 (2006.01) EP 2527329Crystalline forms and processes for the preparation of phenyl-pyrazoles useful as modulators ofthe 5-ht2a serotonin receptorA61K 31/438 (2006.01) EP 2468748 Pyrazoloquinolones are potent parp inhibitorsA61K 31/454 (2006.01) EP 2526946A61K 31/4545 (2006.01) EP 2522664 Piperidine derivatives as NK1 antagonistsMethods Using 3-(4-Amino-1-Oxo-1,3-Dihydro-Isoindol-2-Yl)-Piperidine-2,6-Dione ForTreatment Of Certain LeukemiasSynthesis of (2S,5R)-5-ethynyl-1-{N-(4-methyl-1-(4-carboxy-pyridin-2-yl)piperidin-4-yl)glycyl}pyrrolidine-2-carbonitrileA61K 31/4545 (2006.01) EP 2535338A61K 31/519 (2006.01) EP 2518074 Phosphoinositide 3-kinase inhibitor compounds and methods of useA61K 31/5377 (2006.01) EP 2518074 Phosphoinositide 3-kinase inhibitor compounds and methods of useA61K 31/55 (2006.01) EP 2377557 Compositions comprising azelastine and methods of use thereofA61K 31/55 (2006.01) EP 2522365 Compositions comprising azelastine and methods of use thereofA61K 38/00 (2006.01) EP 2500030 Use of complement pathway inhibitors to treat ocular diseasesA61K 38/17 (2006.01) EP 2524700 Mucinous glycoprotein (muc-1) vaccineA61K 38/45 (2006.01) EP 2484763 Neukinase, a downstream protein of neuregulinA61K 39/00 (2006.01) EP 2520310 Cellular permissivity factor for viruses, and uses thereofA61K 39/00 (2006.01) EP 2524700 Mucinous glycoprotein (muc-1) vaccineA61K 39/145 (2006.01) EP 2578229 Decreasing potential iatrogenic risks associated with vaccine antigensA61K 39/395 (2006.01) EP 2500030 Use of complement pathway inhibitors to treat ocular diseasesA61K 39/395 (2006.01) EP 2520588 Dual variable domain immunoglobulin and uses thereofMethods Using 3-(4-Amino-1-Oxo-1,3-Dihydro-Isoindol-2-Yl)-Piperidine-2,6-Dione ForTreatment Of Certain LeukemiasA61K 39/395 (2006.01) EP 2526946A61K 39/395 (2006.01) EP 2527370 Compounds having resistance to soluble CEAA61K 45/06 (2006.01) EP 2377557 Compositions comprising azelastine and methods of use thereofA61K 45/06 (2006.01) EP 2522365 Compositions comprising azelastine and methods of use thereofA61K 47/32 (2006.01) EP 2377557 Compositions comprising azelastine and methods of use thereofA61K 47/32 (2006.01) EP 2522365 Compositions comprising azelastine and methods of use thereofA61K 48/00 (2006.01) EP 2500030 Use of complement pathway inhibitors to treat ocular diseasesA61K 48/00 (2006.01) EP 2602326 Methods for transfecting nucleic acids into live cellsA61K 9/00 (2006.01) EP 2377557 Compositions comprising azelastine and methods of use thereofA61K 9/00 (2006.01) EP 2522365 Compositions comprising azelastine and methods of use thereofA61K 9/70 (2006.01) EP 2377557 Compositions comprising azelastine and methods of use thereofA61K 9/70 (2006.01) EP 2522365 Compositions comprising azelastine and methods of use thereofA61P 25/00 (2006.01) EP 2520588 Dual variable domain immunoglobulin and uses thereofA61P 29/00 (2006.01) EP 2610244 Indole compoundsSynthesis of (2S,5R)-5-ethynyl-1-{N-(4-methyl-1-(4-carboxy-pyridin-2-yl)piperidin-4-yl)glycyl}pyrrolidine-2-carbonitrileA61P 3/10 (2006.01) EP 2535338A61P 35/00 (2006.01) EP 2468748 Pyrazoloquinolones are potent parp inhibitorsA61P 35/00 (2006.01) EP 2518074 Phosphoinositide 3-kinase inhibitor compounds and methods of useA61P 35/00 (2006.01) EP 2524700 Mucinous glycoprotein (muc-1) vaccineA61P 35/02 (2006.01) EP 2526946Methods Using 3-(4-Amino-1-Oxo-1,3-Dihydro-Isoindol-2-Yl)-Piperidine-2,6-Dione ForTreatment Of Certain LeukemiasCrystalline forms and processes for the preparation of phenyl-pyrazoles useful as modulators ofthe 5-ht2a serotonin receptorA61P 7/00 (2006.01) EP 2527329C07C 403/10 (2006.01) EP 2397130 Retinal derivatives and methods for the use thereof for the treatment of visual disordersC07C 403/12 (2006.01) EP 2397130 Retinal derivatives and methods for the use thereof for the treatment of visual disordersC07C 403/14 (2006.01) EP 2397130 Retinal derivatives and methods for the use thereof for the treatment of visual disordersC07C 403/20 (2006.01) EP 2397130 Retinal derivatives and methods for the use thereof for the treatment of visual disordersC07D 209/18 (2006.01) EP 2610244 Indole compoundsCrystalline forms and processes for the preparation of phenyl-pyrazoles useful as modulators ofthe 5-ht2a serotonin receptorC07D 231/12 (2006.01) EP 2527329C07D 307/28 (2006.01) EP 2522663 Intermediates for the preparation of halichondrin BC07D 307/33 (2006.01) EP 2522663 Intermediates for the preparation of halichondrin BC07D 307/87 (2006.01) EP 2385044 Orodispersible tablet and process for preparing the sameC07D 317/58 (2006.01) EP 2612858 STAT3/5 activation inhibitorC07D 401/04 (2006.01) EP 2522664 Piperidine derivatives as NK1 antagonistsC07D 401/04 (2006.01) EP 2535338Synthesis of (2S,5R)-5-ethynyl-1-{N-(4-methyl-1-(4-carboxy-pyridin-2-yl)piperidin-4-yl)glycyl}pyrrolidine-2-carbonitrileISSN 1847-3024